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 This new journal was therefore introduced to empha-
size the relation between genotype and phenotype with 
special focus on translating molecular findings into med-
ical practice. 
 Molecular Syndromology publishes research articles, 
short reports and reviews on common and rare genetic 
syndromes, aiming to increase clinical understanding 
through molecular insights. Topics of particular interest 
are the molecular basis of genetic syndromes, genotype-
phenotype correlation, natural history, strategies in dis-
ease management and novel therapeutic approaches 
based on molecular findings. Research on model systems 
is also welcome, when it is obviously relevant to medical 
genetics. With high-quality reviews and special issues de-
voted to current topics the journal aims to facilitate early 
transfer of research findings to a clinical setting while 
also stimulating further research on medically relevant 
questions. The feature of ‘Calls for Collaborative and In-
teractive Research Projects’ enables joining of forces in 
very rare disorders. The journal targets not only medical 
geneticists and basic biomedical researchers, but also 
 clinicians dealing with genetic syndromes. With four 
 Associate Editors from three continents and a broad in-
ternational Editorial Board the journal welcomes sub-
missions covering the latest research from around the 
world.
 I therefore trust that you will find  Molecular Syndro-
mology a useful and trustworthy companion in your 
medical research and clinical practice.
 Anita Rauch 
 During the last decade, research addressing either the 
underlying cause of rare genetic disorders or the genetic 
components of complex diseases has tremendously eluci-
dated our understanding of disease causing mechanisms 
in all medical specialties. The enormous technical prog-
ress enabling these developments has also revolutionized 
the diagnostic yield in previously clinically obscure con-
ditions. Karyotyping by means of microscopic analysis of 
stained chromosomes for examples is about to be re-
placed by molecular karyotyping using microarrays with 
millions of probes to detect minimal aberrations far be-
yond the capability of the human eye. Sequencing of 
genes is no longer limited to the detection of the disease 
causing mutation in clinically unambiguous cases for re-
productive management, but has become an indispens-
able tool for establishing a diagnosis especially in am-
biguous cases. In the light of this technical revolution, 
genetic syndromology, the art of recognizing a certain 
condition through a more or less characteristic and often 
very variable combination of clinical signs and the knowl-
edge about the natural history of these syndromes was 
written off by many geneticists. Along with this attitude 
reports of molecular genetic findings especially in high 
ranking journals often neglected clinical detail. Howev-
er, the previously unimagined flood of information aris-
ing through very high resolution karyotyping and antic-
ipated at the dawn of massive parallel sequencing, rein-
structs us about the importance of the thorough clinical 
observation as a prerequisite to turn molecular data into 
useful medical information. 
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